Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,254 | -30,146 | -17,792 | -8,873 | N/A |
| Depreciation Amortization | 168 | 182 | 150 | 49 | N/A |
| Accounts receivable | 681 | -212 | -469 | N/A | N/A |
| Accounts payable and accrued liabilities | -461 | 2,095 | 1,964 | 2,380 | N/A |
| Other Working Capital | -954 | 854 | 1,965 | 1,843 | N/A |
| Other Operating Activity | 2,464 | -314 | -768 | -1,770 | 0 |
| Operating Cash Flow | $-38,356 | $-27,541 | $-14,950 | $-6,371 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -45 | -1,330 | -221 | N/A |
| Other Investing Activity | 0 | 226 | -251 | -29 | 0 |
| Investing Cash Flow | $-5 | $181 | $-1,581 | $-250 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 33,330 | 52,922 | 4 | 22 | N/A |
| Other Financing Activity | 0 | 0 | 7,071 | 25,398 | 0 |
| Financing Cash Flow | $33,330 | $52,922 | $7,075 | $25,420 | $N/A |
| Beginning Cash Position | 42,370 | 16,808 | 26,264 | 7,465 | N/A |
| End Cash Position | 37,339 | 42,370 | 16,808 | 26,264 | N/A |
| Net Cash Flow | $-5,031 | $25,562 | $-9,456 | $18,799 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,356 | -27,541 | -14,950 | -6,371 | N/A |
| Capital Expenditure | -5 | -45 | -1,330 | -221 | N/A |
| Free Cash Flow | -38,361 | -27,586 | -16,280 | -6,592 | 0 |